Showing 3,453 news articles about HIV treatment

Filters Content type: News Topic: HIV treatment

Treatment is recommended for all people living with HIV. It involves taking a combination of antiretroviral drugs. This stops the virus from replicating and allows the immune system to strengthen and fight infections.

TB epidemiology

Zambian patients on dolutegravir and recycled tenofovir regimens have high risk of TB even after switch

News
31 August 2022
New & experimental HIV treatments

European Commission approves first twice-yearly HIV medication

News
25 August 2022
Bone & joint problems

Vitamin D and calcium supplements suggested to avert bone disease in people taking tenofovir-based ART and PrEP

News
24 August 2022
Injectable & long-acting HIV treatment

Long-acting cabotegravir and rilpivirine may be feasible for people without viral suppression

News
23 August 2022
The search for a cure

A cure must be a cure for all: why more HIV cure research in Africa is needed

News
22 August 2022
Injectable & long-acting HIV treatment

New formulations and alternative injection sites might allow self-administration of long-acting cabotegravir and rilpivirine

News
9 August 2022
Violence

Adolescents and women who experience violence more likely to get HIV and less likely to control it

News
2 August 2022
Hepatitis B

Biktarvy combination pill may be most effective option for people with HIV and hepatitis B

News
31 July 2022
Weight gain & lipodystrophy

Weight gain on treatment: more evidence that TAF plus dolutegravir leads to greater gains

News
29 July 2022
PrEP programmes & uptake

Better PrEP retention strategies are needed, as increasing numbers of ex-PrEP users are diagnosed with HIV

News
11 July 2022
Climate change

HIV treatment adherence may be another casualty of climate change

News
8 July 2022
Improving HIV care

How PEPFAR countries sustained HIV programmes in 2020 amidst COVID-19

News
22 June 2022
Weight gain & lipodystrophy

Substantial weight gain as dolutegravir is rolled out in Africa

News
21 June 2022
Cardiovascular disease

Integrase inhibitors raise the risk of heart attack, stroke during first two years of treatment

News
14 June 2022
Treatment guidelines

World’s largest HIV treatment programme could shift almost entirely to WHO-preferred first line regimen

News
7 June 2022
Resistance

Dolutegravir resistance showing up after prolonged periods on failing treatment

News
2 June 2022
Health problems & ageing

Which health conditions are more or less common in people with HIV?

News
30 May 2022
Diabetes

Women with HIV at greater risk of diabetes than men

News
19 May 2022
Diabetes

Obesity more important than integrase inhibitors in risk for developing diabetes in people with HIV

News
19 May 2022
Antibody-based treatment

Repeated infusions of two antibodies delay viral rebound but don’t prevent it

News
13 May 2022
Weight gain & lipodystrophy

High rates of obesity among middle-aged Black women with HIV in UK cohort

News
10 May 2022
Mental & emotional health problems

Antidepressants improve ART adherence and quality of life in HIV-positive men with depression

News
9 May 2022
HIV treatment for children & young people

High levels of infant resistance to abacavir and tenofovir in Namibia

News
6 May 2022
Treatment outcomes & life expectancy

A quarter of 2020 deaths of people with HIV in the UK due to COVID-19

News
21 April 2022